Photo from Andres Gomez/Twitter
Nov 20, 2023, 03:53
Andres Gomez: This is why we developed a phase 2 study with outpatient ven-aza instead of 7+3
Andres Gomez, Associate Professor at the Autonomous University of Nuevo León, Monterrey, Mexico, posted on X/Twitter:
“This is why we developed a phase 2 study with outpatient ven-aza instead of 7+3 and why Yadith Lopez will present a poster comparing pre-post outcomes in the American Society of Hematology 23.
AML in India commentary The Lancet Haematology mirrors Mexico.”
For the article click here.
Source: Andres Gomez/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14